G.Bringmann, J.Wu et al.
with tetramethylsilane as the internal standard.Preparative HPLC was
carried out on ODS columns (25010 mm i.d., YMC) with a Waters 996
photodiode array detector.For column chromatography, silica gel (200–
300 mesh) (Qingdao Mar.Chem.Ind). was used.( R)-, (S)-MTPACl and
(dimethylamino)pyridine (DMAP) were purchased from Sigma–Aldrich.
J=6.7 Hz, H19), 1.89 (dt, J=14.5, 4.0 Hz, H12a), 2.14 (dt, J=16.0, 4.0,
H11a), 2.33 (m, H6a), 2.36 (m, H5), 2.38 (m, H12b), 2.46 (dt, J=16.0,
5.0 Hz, H11b), 2.54 (m, H6b), 2.56 (m, H10), 3.35 (s, 3-OCH3), 3.63 (s,
H3), 3.68 (s, 7-OCH3), 5.52 (s, H17), 6.39 (s, H15), 6.54 (brs, H22), 7.14
(s, H30), 7.53 (brs, H23), 7.67 ppm (brs, H21); 13C NMR (see Table 2);
IR (film): n˜ =3434, 2939, 2374, 1710, 1631, 1583, 1385, 1270, 1164, 1089,
1028, 874, 804, 603 cmÀ1; UV (MeOH): lmax (loge)=212 (4.09), 335 nm
(4.19); HRTOF-MS: m/z: calcd for C28H34O9Na: 537.2101; found:
537.2112 [M+Na]+.
Xylogranatin L (7): Amorphous powder, [a]2D5 =À37 (c=0.12 in MeOH);
1H NMR (CD3OD): d=0.77 (s, H28), 1.09 (s, H29), 1.20 (t, J=7.0 Hz, 3-
OCH2CH3), 1.30 (s, H18), 1.36 (d, J=6.7 Hz, H19), 1.93 (dt, J=14.5,
4.0 Hz, H12a), 2.16 (dt, J=16.0, 4.0 Hz, H11a), 2.36 (m, H6a), 2.39 (m,
H12b), 2.40 (m, H5), 2.47 (dt, J=16.0, 5.0 Hz, H11b), 2.57 (m, H6b), 2.60
(m, H10), 3.52 (m, 3-OCH2CH3), 3.67 (m, 3-OCH2CH3), 3.71 (s, 7-
OCH3), 3.76 (s, H3), 5.55 (s, H17), 6.41 (s, H15), 6.57 (brs, H22), 7.13 (s,
H30), 7.56 (brs, H23), 7.70 ppm (brs, H21); 13C NMR (see Table 2); IR
(film): n˜ =3435, 2973, 2376, 1715, 1632, 1583, 1385, 1271, 1165, 1086,
1027, 875, 802, 603 cmÀ1; UV (MeOH): lmax (loge)=212 (4.15), 336 nm
(4.21); HRTOF-MS: m/z: calcd for C29H36O9Na: 551.2257 [M+Na]+;
found: 551.2268.
Xylogranatin M (8): Amorphous powder, [a]2D5 =À52 (c=0.15 in MeOH);
1H NMR (CD3OD): d=0.87 (s, H28), 1.04 (s, H29), 1.27 (s, H18), 1.36 (d,
J=6.7 Hz, H19), 1.94 (dt, J=14.5, 4.0 Hz, H12a), 2.07 (s, 3-OCOCH3),
2.19 (dt, J=16.0, 4.0 Hz, H11a), 2.35 (m, H12b), 2.40 (m, H5), 2.43 (m,
H6a), 2.52 (dt, J=16.0, 5.0 Hz, H11b), 2.62 (m, H6b), 2.65 (m, H10), 3.64
(s, 9-OCH3), 3.73 (s, 7-OCH3), 5.31 (s, H3), 5.53 (s, H17), 6.40 (s, H15),
6.55 (brs, H22), 7.01 (s, H30), 7.56 (brs, H23), 7.69 ppm (brs, H21);
13C NMR (see Table 2); IR (film): n˜ =3435, 2971, 2375, 1732, 1631, 1588,
1384, 1242, 1166, 1129, 1024, 875, 806, 604 cmÀ1; UV (MeOH): lmax
(loge)=212 (4.10), 336 nm (4.11); HR-TOFMS: m/z: calcd for
C30H36O10Na: 579.2206 [M+Na]+; found: 579.2214.
Plant material: Four batches of the seeds of Xylocarpus granatum were
collected in October and November 2005, and in January and March
2006 from the Hainan Island (Southern China).The identification of the
plant was performed by Prof.Yongshui Lin, Laboratory of Marine Biol-
ogy, South China Sea Institute of Oceanology, Chinese Academy of Sci-
ences.Voucher samples (nos.GKLMMM-002–4 to GKLMMM-002–7)
are maintained in the Herbarium of the South China Sea Institute of
Oceanology.
Extraction and isolation: Four batches of the dried seeds (4, 6, 6, and
8 kg, each) of X. granatum were crushed and extracted three times with
95% ethanol at room temperature.The extract was concentrated and
partitioned between water and petroleum ether.Then the aqueous layer
was further extracted with ethyl acetate and concentrated to give a
brown gum, which was subjected to silica-gel chromatography (chloro-
form/methanol 100:0 to 2:1).The fractions that were eluted with chloro-
form/methanol (25:1 to 15:1) were combined and purified by preparative
HPLC (YMC-Pack ODS-5 A, 25020 mm i.d., acetonitrile/water 30:70
to 45:55) to yield xylogranatins F (1, 20 mg), G (2, 22 mg), H (3, 4 mg), I
(4, 40 mg), J (5, 8 mg), K (6, 20 mg), L (7, 6 mg), M (8, 3 mg), N (9,
6 mg), O (10, 7 mg), P (11, 6 mg), Q (12, 35 mg), R (13, 12 mg), and C[20]
(60 mg).Additionally, xylogranatin C was stored for two weeks dissolved
in methanol at room temperature; after this time, it was purified by
HPLC to afford xylogranatin D[20] (35 mg).
Xylogranatin F (1): Amorphous powder, [a]2D5 =+254 (c=0.21 in MeCN);
1H and 13C NMR (see Table 1); IR (film): n˜ =3420, 2970, 1772, 1712,
1595, 1440, 1365, 1239, 1161, 1129, 1061, 1027, 942, 875, 697, 602 cmÀ1
;
UV (MeOH): lmax (loge) = 210 (4.23), 268 (4.01), 310 nm (4.07); HR-
TOFMS: m/z: calcd for C26H27NO6Na: 472.1736 [M+Na]+; found:
472.1724.
Xylogranatin N (9): Amorphous powder, [a]2D5 =À41 (c=0.15 in MeOH);
1H NMR (CD3OD): d=0.88 (s, H28), 1.04 (s, H29), 1.25 (s, H18), 1.38 (d,
J=6.7 Hz, H19), 1.92 (m, H12a), 2.14 (m, H11a), 2.34 (m, H12b), 2.42
(m, H5), 2.43 (m, H11b), 2.45 (m, H6a), 2.62 (m, H6b), 2.65 (m, H10),
3.73 (s, 7-OCH3), 5.29 (s, H3), 5.53 (s, H17), 6.39 (s, H15), 6.54 (brs,
H22), 7.00 (s, H30), 7.54 (brs, H23), 7.69 ppm (brs, H21); 3-O-(2S)meth-
ylbutyryl: 0.86 (t, J=7.4 Hz, H4’), 1.13 (d, J=7.0 Hz, H5’), 1.50 (m, H3’),
1.65 (m, H3’), 2.38 ppm (m, H2’); 13C NMR (see Table 2); UV (MeOH):
lmax (loge)=212 (4.06), 335 nm (4.11); IR (film): n˜ =3434, 2970, 2375,
Xylogranatin G (2): Amorphous powder, [a]2D5 +105 (c=0.15 in MeCN);
1H and 13C NMR (see Table 1); IR (film): n˜ =3447, 2972, 1776, 1726,
1596, 1440, 1373, 1233, 1160, 1082, 1062, 1023, 937, 875, 697, 605 cmÀ1
;
UV (MeOH): lmax (loge)=208 (4.21), 270 (3.89), 310 nm (3.96); HR-
TOFMS: m/z: calcd for C28H29NO7: 491.1944 [M]+; found: 491.1947.
Xylogranatin H (3): Amorphous powder, [a]2D5 =+14 (c=0.12 in MeCN);
1H and 13C NMR (see Table 1); IR (film): n˜ =3447, 2933, 1736, 1632,
1384, 1238, 1163, 1027, 944, 875, 602 cmÀ1; UV (MeOH): lmax (loge)=217
(4.03), 280 nm (4.01); HR-TOFMS: m/z: calcd for C26H29NO6Na:
474.1893 [M+Na]+; found: 474.1884.
Xylogranatin I (4): Amorphous powder, [a]2D5 =À20 (c=0.20 in MeOH);
1H NMR (CD3OD): d=0.76 (s, H28), 1.05 (s, H29), 1.27 (s, H18), 1.36 (d,
J=6.7 Hz, H19), 1.92 (dt, J=14.5, 4.0 Hz, H12a), 2.17 (dt, J=16.0,
4.0 Hz, H11a), 2.32 (m, H5), 2.35 (m, H6a), 2.57 (m, H6b), 2.38 (m,
H12b), 2.47 (dt, J=16.0, 5.0 Hz, H11b), 2.60 (m, H10), 3.70 (s, 7-OCH3),
4.05 (s, H3), 5.52 (s, H17), 6.39 (s, H15), 6.53 (brs, H22), 7.08 (s, H30),
7.67 (brs, H21), 7.53 ppm (brs, H23); 13C NMR (see Table 2); IR (film):
n˜ =3436, 2970, 1631, 1582, 1384, 1027, 874, 603 cmÀ1; UV (MeOH): lmax
(loge)=213 (4.09), 336 nm (4.12); HR-TOFMS: m/z: calcd for C27H32O9:
500.2046 [M]+; found: 500.2052.
1721, 1631, 1587, 1384, 1267, 1186, 1027, 875, 807, 603 cmÀ1
; HR-
TOFMS: m/z: calcd for C32H40O10Na: 607.2519 [M+Na]+; found:
607.2531.
Xylogranatin O (10): Amorphous powder, [a]2D5 =À28 (c=0.11 in
MeOH); 1H NMR (CD3OD): d=0.89 (s, H28), 1.03 (s, H29), 1.27 (s,
H18), 1.39 (d, J=6.7 Hz, H19), 1.93 (m, H12a), 2.14 (m, H11a), 2.34 (m,
H12b), 2.45 (m, H11b), 2.46 (m, H6a), 2.50 (m, H5), 2.63 (m, H6b), 2.67
(m, H10), 3.73 (s, 7-OCH3), 5.33 (s, H3), 5.54 (s, H17), 6.40 (s, H15), 6.56
(brs, H22), 7.04 (s, H30), 7.55 (brs, H23), 7.70 ppm (brs, H21); 3-O-tiglo-
yl: 1.83 (d, J=7.1 Hz, H4’), 1.85 (s, H5’), 6.89 ppm (q, J=7.1 Hz, H3’);
13C NMR (see Table 2); IR (film): n˜ =3435, 2950, 2375, 1708, 1631, 1385,
1263, 1084, 1023, 875, 806, 603 cmÀ1; UV (MeOH): lmax (loge)=212
(4.18), 335 nm (4.00); HR-TOFMS: m/z: calcd for C32H38O10Na: 605.2363
[M+Na]+; found: 605.2374.
Xylogranatin J (5): Amorphous powder, [a]2D5 =À73 (c=0.10 in MeOH);
1H NMR (CD4OD): d=0.77 (s, H28), 1.08 (s, H29), 1.31 (s, H18), 1.34 (d,
J=6.7 Hz, H19), 1.95 (dt, J=14.5, 4.0 Hz, H12a), 2.20 (dt, J=16.0,
4.0 Hz, H11a), 2.37 (m, H6a), 2.38 (m, H5), 2.40 (m, H12b), 2.53 (dt, J=
16.0, 5.0 Hz, H11b), 2.58 (m, H6b), 2.59 (m, H10), 3.38 ppm (s, 3-OCH3),
3.63 (s, 9-OCH3), 3.66 (s, H3), 3.71 (s, 7-OCH3), 5.54 (s, H17), 6.41 (s,
H15), 6.56 (brs, H22), 7.16 (s, H30), 7.56 (brs, H23), 7.70 ppm (brs,
H21); 13C NMR (see Table 2); IR (film): n˜ =3435, 2932, 2375, 1631, 1581,
1406, 1385, 1027, 832, 620 cmÀ1; UV (MeOH): lmax (loge)=212 (4.12),
335 nm (4.13); HRTOF-MS m/z: calcd for C29H36O9Na: 551.2257
[M+Na]+; found: 551.2237.
Xylogranatin P (11): Amorphous powder, [a]2D5 =À36 (c=0.11 in
MeOH); 1H NMR (CD3OD): d=0.87 (s, H28), 1.04 (s, H29), 1.26 (s,
H18), 1.39 (d, J=6.7 Hz, H19), 1.95 (m, H12a), 2.13 (m, H11a), 2.33 (m,
H12b), 2.36 (m, H11b), 2.44 (m, H5), 2.44 (m, H6a), 2.63 (m, H6b), 2.65
(m, H10), 3.73 (s, 7-OCH3), 5.29 (s, H3), 5.54 (s, H17), 6.40 (s, H15), 6.56
(brs, H22), 7.01 (s, H30), 7.54 (brs, H23), 7.70 ppm (brs, H21); 3-O-iso-
butyryl: 1.13 (d, J=7.0 Hz, H4’), 1.17 (d, J=7.0 Hz, H3’), 2.58 ppm (m,
H2’); 13C NMR (see Table 2); IR (film): n˜ =3435, 2972, 2375, 1631, 1587,
1385, 1160, 1027, 875, 651 cmÀ1; UV (MeOH): lmax (loge)=212 (4.12),
335 nm (4.16); HR-TOFMS: m/z: calcd for C31H38O10Na: 593.2363
[M+Na]+; found: 593.2373.
Xylogranatin K (6): Amorphous powder, [a]2D5 =À31 (c=0.13 in MeOH);
Xylogranatin Q (12): Amorphous powder, [a]2D5 =À38 (c=0.13 in
1H NMR (CD3OD): d=0.74 (s, H28), 1.05 (s, H29), 1.28 (s, H18), 1.32 (d,
MeOH); 1H NMR (CD3OD): d=1.08 (s, H28), 1.15 (s, H29), 1.31 (s,
1142
ꢀ 2008 Wiley-VCH Verlag GmbH & Co.KGaA, Weinheim
Chem. Eur. J. 2008, 14, 1129 – 1144